Stockreport

Blacksmith Medicines Announces $3.3M in Funding from NIAID to Support Clinical Trial Manufacturing of Novel Antibiotic [Yahoo! Finance]

Cyteir Therapeutics, Inc.  (CYT) 
PDF targeting metalloenzymes, announced today the release of $3.3M from its contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the Nati [Read more]